Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.41 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.38 |
| ▸ | FFAR1 | O14842 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | CDK8 | P49336 | 1/20 | 0.35 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.33 |
| ▸ | BACE1 | P56817 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HTR7 | P34969 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | HTR1A | P08908 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8477404 | 0.79 | TDP1 (0.38) | TDP1BACE1ALDH1A1MAPT | |
| SCHEMBL8474671 | 0.73 | BACE1 (0.33) | BACE1 | |
| SCHEMBL8480981 | 0.70 | PTGS2 (0.46) | BACE1KDM4E | |
| SCHEMBL8477428 | 0.69 | PTGS2 (0.40) | FFAR1KDM4EALDH1A1MAPTPDE4B | |
| SCHEMBL2571534 | 0.67 | TAAR1 (0.55) | ACMSDMAP4K4TDP1CDK8BACE1 | |
| SCHEMBL11040917 | 0.66 | CALM1 (0.38) | TDP1ALDH1A1MAPT | |
| SCHEMBL5865105 | 0.66 | TDP1 (0.62) | ACMSDMAP4K4FFAR1TDP1CDK8 | |
| SCHEMBL7464716 | 0.66 | GCGR (0.38) | KDM4EALDH1A1MAPT | |
| SCHEMBL8473979 | 0.65 | DHFR (0.34) | KDM4EALDH1A1MAPT | |
| SCHEMBL239199 | 0.65 | TDP1 (0.65) | ACMSDMAP4K4TDP1CDK8CYP4F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2297085-A2 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | Allergan, Inc. (US) | 2011-03-23 | — | — | EP | disclosed |
| EP-2291353-A1 | THERAPEUTIC PROSTAGLANDIN COMPOUNDS USED AS OCULAR HYPOTENSIVE AGENTS | Allergan, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| WO-2009142967-A1 | THERAPEUTIC PROSTAGLANDIN COMPOUNDS USED AS OCULAR HYPOTENSIVE AGENTS | ALLERGAN, INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| WO-2009137411-A1 | THERAPEUTIC COMPOUNDS | ALLERGAN, INC. (US) | 2009-11-12 | — | — | WO | disclosed |
| EP-2114875-A1 | SUBSTITUTED ARYLCYLOPENTENES AS THERAPEUTIC AGENTS | Allergan, Inc. (US) | 2009-11-11 | — | — | EP | disclosed |
| WO-2009132093-A2 | SUBSTITUTED ARYLCYCLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2009-10-29 | — | — | WO | disclosed |
| EP-2069295-A2 | SUBSTITUTED CYCLOPENTANE DERIVATIVES AS THERAPEUTIC AGENTS | Allergan, Inc. (US) | 2009-06-17 | — | — | EP | disclosed |
| EP-2066615-A2 | CYCLOPENTANE DERIVATIVES AS ANTIGLAUCOMA AGENTS | Allergan, Inc. (US) | 2009-06-10 | — | — | EP | disclosed |
| EP-2046714-A2 | THERAPEUTIC COMPOUNDS | Allergan, Inc. (US) | 2009-04-15 | — | — | EP | disclosed |
| EP-2043993-A2 | CYCLOPENTANE DERIVATIVES AS ANTIGLAUCOMA AGENTS | Allergan, Inc. (US) | 2009-04-08 | — | — | EP | disclosed |
| WO-2008091810-A1 | SUBSTITUTED ARYLCYLOPENTENES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2008-07-31 | — | — | WO | disclosed |
| WO-2008008700-A2 | SUBSTITUTED CYCLOPENTANE DERIVATIVES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008701-A2 | SUBSTITUTED CYCLOPENTANE DERIVATIVES AS THERAPEUTIC AGENTS | ALLERGAN, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008660-A2 | CYCLOPENTANE DERIVATIVES AS ANTIGLAUCOMA AGENTS | ALLERGAN, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2008008718-A2 | CYCLOPENTANE DERIVATIVES AS ANTIGLAUCOMA AGENTS | ALLERGAN, INC. (US) | 2008-01-17 | — | — | WO | disclosed |
| WO-2007149829-A2 | THERAPEUTIC COMPOUNDS | ALLERGAN, INC. (US) | 2007-12-27 | — | — | WO | disclosed |